Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2081195 | Drug Discovery Today | 2006 | 9 Pages |
Abstract
Antidepressant medications have eased the suffering of millions of people. In addition to treating depression, antidepressant drugs also treat several anxiety disorders. Unfortunately, there are problematic limitations with antidepressant agents, including a delayed therapeutic response and insufficient efficacy. Emerging evidence shows that atypical antipsychotic agents can be used as augmentation therapy in patients with poor responses to antidepressants. Future drugs combining key features of antidepressant and atypical antipsychotic agents could offer new promise for patients suffering from obsessive–compulsive disorder, post-traumatic stress disorder, panic disorder, generalized anxiety disorder and depression.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Kurt Rasmussen,